FAM151A Inhibitors
Chemical inhibitors of FAM151A, a protein implicated in specific cellular processes, operate through distinct mechanisms to diminish itsactivity. Staurosporine, a broad-spectrum kinase inhibitor, reduces the activity of kinases that may phosphorylate proteins interacting with or regulating FAM151A. Consequently, the decreased phosphorylation leads to a reduction in FAM151A activity. Rapamycin, by inhibiting mTOR, indirectly decreases the synthesis of proteins that facilitate FAM151A's function, while LY 294002 and Wortmannin, as PI3K inhibitors, potentially reduce AKT signaling, affecting the phosphorylation status of FAM151A-related proteins. PD 98059 and U0126, both targeting the MEK pathway, and SB 203580, an inhibitor of p38 MAPK, alter the MAPK signaling cascade, which may indirectly influence FAM151A's functional activity through downstream protein interactions. SP600125's inhibition of JNK signaling could also diminish FAM151A activity if JNK supports proteins regulating FAM151A.
Furthermore, BIX02188's inhibition of MEK5 and Y-27632's inhibition of ROCK both could decrease FAM151A's activity by disrupting ERK5 signaling and altering cytoskeletal dynamics, respectively. JWH 073, targeting RAF kinase, may reduce FAM151A's function through diminished MAPK/ERK pathway signaling. Lastly, Gefitinib's inhibition of EGFR could decrease tyrosine kinase activity, indirectly influencing downstream pathways that FAM151A is involved in, leading to reduced activity of the protein. Collectively, these inhibitors disrupt various signaling pathways and protein interactions that are necessary for FAM151A's functional maintenance within cellular processes, thereby leading to its decreased activity without directly inhibiting its expression or translation. Each inhibitor's specific mechanism provides a unique approach to diminishing the activity of FAM151A, offering a comprehensive view of the potential regulatory landscape for this protein's function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent protein kinase inhibitor that can lead to the inhibition of downstream proteins indirectly associated with FAM151A function. By diminishing the activity of various kinases, staurosporine may reduce the phosphorylation state of proteins that interact with or regulate FAM151A, thereby decreasing its functional activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can indirectly lead to the downregulation of protein synthesis pathways in which FAM151A may be involved. By inhibiting mTOR, rapamycin may reduce the activity of proteins that are necessary for the functional maintenance of FAM151A, leading to its diminished functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is a PI3K inhibitor that could lead to the inhibition of AKT signaling, thereby potentially affecting the phosphorylation and activity of proteins related to the functions of FAM151A. This indirect inhibition could result in diminished support for FAM151A's activity within the cell. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is an MEK inhibitor that can interfere with the MAPK/ERK pathway, which may be involved in processes that support FAM151A function. By inhibiting MEK, PD 98059 could decrease the phosphorylation of downstream proteins that might interact with FAM151A, leading to a decrease in FAM151A functional activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a p38 MAPK inhibitor that can diminish the p38-mediated signaling involved in inflammatory responses and possibly other cellular processes that may include FAM151A. This inhibition could decrease the functional activity of FAM151A by reducing the activity of proteins that are modulated by the p38 MAPK pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that prevents AKT activation and can indirectly affect the functional activity of FAM151A by inhibiting signaling pathways that support FAM151A's cellular role. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor which may diminish JNK signaling pathways that could indirectly affect cellular processes involving FAM151A. By reducing JNK activity, this could lead to decreased functional activity of FAM151A if JNK signaling supports proteins that interact with or regulate FAM151A. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2 which could reduce ERK pathway signaling, potentially affecting proteins that function in conjunction with FAM151A. This could lead to a decrease in FAM151A's functional activity through diminished ERK pathway signaling. | ||||||
BIX02188 | 1094614-84-2 | sc-503854 | 10 mg | $380.00 | ||
BIX02188 is an MEK5 inhibitor which can reduce ERK5 signaling, potentially affecting proteins that have a functional relationship with FAM151A. This decrease in ERK5 activity could lead to a decrease in the functional activity of FAM151A. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that can lead to changes in cytoskeletal dynamics and cellular tension. As these processes may influence the activity of FAM151A indirectly, the inhibition of ROCK could lead to a decrease in FAM151A's functional activity by altering the cellular architecture and protein interactions. | ||||||